Chlorfenson is developed by Moberg Derma for the treatment of onychomycosis (nail fungus) as the primary indication.
- Mechanism
- Curator reviewed
Chlorfenson is a topical solution applied once-daily on affected nails during treatment periods of 3-6 months. In pilot studies, Chlorfenson has shown promising results and provides important benefits compared to existing treatment alternatives. There is a significant need for more efficacious topical treatments. For more severe cases of the disease where more than 50% of the nail is affected, the only available options are oral anti-fungals which are associated with a certain risk for severe side effects.
- Primary indication
- Investigated for use/treatment in fungal infections.Curator reviewed
- Formula / weight
- C12H8Cl2O3S ยท 303.161 g/mol (avg)
- Also known as
- Ester sulfonate
- Code names
- K-101
Resolves to
RZXLPPRPEOUENN-UHFFFAOYSA-NSMILESClC1=CC=C(OS(=O)(=O)C2=CC=C(Cl)C=C2)C=C1Which companies are running trials of Chlorfenson, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account